Open access peer-reviewed chapter

Vitamin E and Derivatives in Skin Health Promotion

Written By

Júlia Scherer Santos, Guilherme Diniz Tavares and Thaís Nogueira Barradas

Submitted: 13 July 2021 Reviewed: 15 July 2021 Published: 17 August 2021

DOI: 10.5772/intechopen.99466

From the Edited Volume

Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects

Edited by Pınar Erkekoglu and Júlia Scherer Santos

Chapter metrics overview

770 Chapter Downloads

View Full Metrics

Abstract

Vitamin E is fundamental for a proper function of human cells. Mostly obtained from vegetable oils, it has antioxidant and non-antioxidant actions. At times, its oral intake or skin application are employed. Oral intake is recommended in some cases. Differently, the topical application is a part of daily skin routine. Both in oral or in topical formulations, it is employed in its isoforms or derivatives. Tocopherols and tocotrienols are isoforms while derivatives are synthetic forms. In pharmaceutical and cosmetic formulations, vitamin E and its derivatives are widely used due to its antioxidant and photoprotective properties. However, the clinical success treatment is often impaired by its low skin penetration, high lipophilicity, and chemical instability. A rational formulation design in the development of novel vitamin E dosage forms is required. In this chapter, the most successful and innovative approaches towards Vitamin E and its derivatives loaded in formulations for skin health promotion are reviewed. Conventional and nanoparticle-based formulations enable vitamin E chemical stabilization, and they are suitable vehicles for its release on the skin. Further, nano-sized carriers can increase vitamin E content in formulations as well as favor its skin penetration.

Keywords

  • antioxidant
  • tocopherols
  • tocotrienols
  • skin
  • health

1. Introduction

Neurodegenerative and metabolic diseases progression is related to oxidative stress [1, 2], a condition where there is a lower ability of endogenous antioxidants to scavenge free radicals [3] resulting in free radicals increase. Most frequent free radicals are the reactive oxygen species (ROS) such as singlet oxygen, hydrogen peroxide and hydroperoxide. ROS are formed endogenously [4] and its production is raised by some environmental factors [3]. Major internal sources are mitochondrial oxidative reactions, phagocytosis by macrophages and xenobiotics metabolization [4]. Environmental factors include pollution, ultraviolet radiation and smoking [3]. Free radicals damage DNA, protein and lipids [4] and their increase is involved in diabetes progression [1] and in Alzheimer and Parkinson’s diseases onset [2]. In addition, cystic fibrosis patients are more prone to oxidative stress owing to vitamin E deficiency [3].

Some endogenous antioxidants are glutathione peroxidase, vitamin C and vitamin E [4]. Vitamin E is a non-enzymatic endogenous antioxidant [4] preventing atherosclerosis due to reduction of low density lipoprotein (LDL) oxidation. Beyond from antioxidant, it has a fundamental role in neurological and immune system function [4]. Accordingly, oral intake of vitamin E would be an interesting alternative treatment to oxidative related diseases to improve patients quality of life [5, 6]. Apart from oral intake, natural sources of this vitamin are the vegetable oils. Wheat germ oil, sunflower oil, rice bran oil, canola oil and palm oil are some representants rich in vitamin E. Nuts and fresh foods contain vitamin E, but in smaller amounts [4].

1.1 Vitamin E isoforms and derivatives

A sum of 4 tocopherols isomers and 4 tocotrienols isomers compose vitamin E. Isomers are named as alpha, beta, gamma and delta and their chemical structures are shown in Figure 1. Tocopherols and tocotrienols differ only in their side chain. Tocotrienols have an unsaturation on its side chain. In respect to isomers, the nomenclature is due to substitutions in R1 and R2 positions. Alpha isomers have a methyl group both at R1 and R2 while delta isomers do not have any methyl group. Instead, beta and gamma isomers have one single methyl group, in R1 or in R2. Regardless of the source, vegetables contain a mixture of isoforms and one of them is predominant [7, 8]. Isoforms are obtained through extraction from vitamin E- rich vegetables such as wheat (shown in Figure 1) whose principal isoform is alpha-tocopherol [7]. Chemical synthesis is employed to obtain alpha-tocopherol [7, 8].

Figure 1.

Extraction of vitamin E isoforms, chemical structure of Tocopherols, Tocotrienols and Tocopheryl acetate. Created in BioRender and ACD/ChemSketch.

Commercially, vitamin E is available mainly as alpha-tocopherol [9, 10] or tocopheryl acetate [11, 12, 13] which are used above all to oral [14, 15] and skin [10, 12, 16] applications, respectively. Among vitamin E derivatives are tocopheryl acetate, tocopheryl glucoside and tocopheryl phosphate. Tocopheryl acetate is the most used vitamin E derivative [17] also named as tocopherol acetate or vitamin E acetate [18]. It is obtained through tocopherol modification to improve stability since tocopherol is a labile form. However, tocopheryl acetate is biologically inactive and it must be converted to tocopherol in skin and intestine. Often, there is no mention about tocopheryl acetate isomer as alpha-tocopheryl acetate is the most used [8].

Regarding human use, there is no standardization about vitamin E dose neither in oral intake [14, 15] nor in skin formulations [10, 19, 20]. Although its deficiency in adults is unusual [4], its oral intake may be recommended in cystic fibrosis patients [21]. Oral supplementation is equally used to reduce ultraviolet damage to skin [14, 15]. Furthermore, its combination with other antioxidants is a common approach. Vitamin C is the most used one [15, 19, 20] because it regenerates oxidized vitamin E [22]. Oxidized vitamin E if not properly regenerated may promote lipid peroxidation instead of preventing it [4]. The association of several antioxidants is then extremely important to reduce oxidative stress.

1.2 Benefits on skin health and dermatological diseases

The knowledge about vitamin E effects is essential to guide its use in dermatological treatments. Table 1 shows some skin effects and mechanisms of action to vitamin E isoforms and derivatives. Photoprotection was approached mostly in earlier studies [23, 27, 28] while current ones approach mostly skin diseases [31, 35]. The antioxidant activity accounts for many skin effects including photoprotection [23, 24, 25], skin aging reduction [36, 37] and pyrimidine dimers reduction. The latter effect is important to prevent cancer onset [30]. Moreover, as reactive oxygen species are involved in the pathogenesis of psoriasis and atopic dermatitis [38, 39, 40], the topical application of vitamin E isoforms would be likewise beneficial in these diseases.

Skin effectMechanism of actionReferences
PhotoprotectionLipid peroxidation reduction[23, 24, 25]
Endogenous antioxidants protection[24, 25, 26]
Erythema decrease[27, 28]
Inflammation reduction[29]
Cancer preventionPyrimidine dimers reduction[30]
Reduction of melanoma progressionApoptosis induction[31, 32]
Cell cycle arrest[32]
Improvement of melasmaReduction of tyrosinase activity[33, 34]
Down-regulation of TYRP-2 expression[34]
Down-regulation of TYR, TYRP-1, TYRP-2*[35]
Reduction of Skin AgingIncreased collagen expression[36, 37]
Decrease metalloproteinases expression[37]

Table 1.

General skin effects and mechanisms of vitamin E isoforms and derivatives.

TYR: Tyrosinase, TYRP-1: tyrosinase-related protein-1, TYRP-2: tyrosinase-related protein- 2.


In relation to isomers, earlier researches were directed mainly to alpha-tocopherol whose action is lipid peroxidation reduction [24]. Nowadays, research is focused on tocotrienols [31] and tocotrienol-rich fraction [35, 36, 37] which are able to reduce melanoma progression [31, 32], melanogenesis [35] and skin aging [36, 37]. Tocotrienol-rich fraction (TRF) is a mixture of tocotrienols and alpha-tocopherol [41] allowing to combine the pharmacological benefits of several isomers. Further studies over tocotrienols and TRF are required to prove their efficacy in skin diseases treatments.

Advertisement

2. Vitamin E in skin care formulations

Conventional formulations [42] and nanotechnological-based formulations [16, 43] have been used to deliver vitamin E and its derivatives into the skin due to its moisturizing, photoprotective, antioxidant [44, 45] and anticancer properties [46]. Some formulations applied to skin care are summarized in Table 2. Mainly sunscreens and anti-aging commercial products contain this vitamin [42]. Additionally, some cosmetic brands have explored the “anti-pollution” claim in their labels. As pollution triggers oxidative stress, the “anti-pollution” effect prevents skin damage induced by pollutants [19].

Skin formulationSkin care applicationVitamin E isoform or derivativeReference
Conventional formulationsPhotoprotectionα-tocopherol[10, 47]
Tocopheryl acetate[48, 49]
Tricotrienol-rich fraction[25]
MelasmaTocopheryl acetate[50]
Anti-pollutionα-tocopherol[19]
Skin agingTocopheryl acetate[51]
Acne vulgarisTocopheryl phosphate[52]
Nanotechnology-based systemsPhotoprotectionTocopheryl acetate[43, 53]
α-tocopherol[54, 55]
Wound healingTocopheryl acetate[56, 57]
Dermatitisα-tocopherol[58, 59]
γ-tocotrienol[59]
Skin agingα-tocopherol[9]
MoisturizationTocopheryl acetate[16]
α-tocopherol[9]

Table 2.

Vitamin E isoforms and derivatives in conventional forms and nanotechnology-based systems.

Nevertheless, several limitations impact vitamin E isoforms and derivatives bioavailability. Their bioactivity in different target sites, such as the skin is affected. Vitamin E is an unstable molecule because it undergoes oxidation, especially the light-triggered phenomena [60]. In this sense, novel drug delivery systems have been extensively investigated to improve vitamin E bioavailability, solubility, stability and biodistribution. Consequently, a better skin penetration can be accomplished [61, 62].

2.1 Conventional formulations

Emulsions and hydroalcoholic gel are the most common conventional formulations bearing either tocopherol, tocopheryl acetate or other esters (succinate, nicotinate, linoleate, and phosphate). The isoform α-tocopherol is the one with the best cost–benefit ratio [42]. One single α-tocopherol molecule is capable of neutralizing 2 peroxidil radicals which is responsible for lipid oxidation initiation. Then, a delay in the development of several oxidation-based disorders could be achieved [38]. Despite being less effective than tocopherol, tocopheryl acetate is widely used in formulations intended to skin delivery [42].

In sunscreens formulations, vitamin E and its derivatives increase the sun protection factor [47] and contribute to the photostabilization of chemical filters [49]. After skin permeation, they can minimize the oxidative stress harmful effects caused by UV radiation [48, 63]. In the latter case, an adequate vehicle is important since it can influence its permeation. In this regard, especially o/w (oil- in-water) emulsions have been used as the vehicle of choice [64]. From this perspective, a report showed that o/w emulsion containing vitamin E prevented erythema induction and reduced inflammatory damage caused by UV exposure in healthy volunteers [48].

In anti-aging formulations, vitamin E and its derivatives act as antioxidants, scavenging free radicals, the principal accelerators of skin aging [65]. As regards to α-tocopherol, it decreased expression lines, wrinkles, and freckles induced by photoaging in a study performed in vivo [66]. In addition, α-tocopherol smooths the skin, increases the stratum corneum ability to maintain its humidity and accelerates the epithelialization process [67]. For these purposes of use, most commercially available formulations are emulsions o/w, both in creams and lotions.

Furthermore, the association of vitamin E and its derivatives with other ingredients increased the effectiveness of different dermocosmetic treatments [45]. In this sense, the application of a lotion combining α-tocopherol phosphate, ascorbyl 2-phosphate 6-palmitate, and glyceryl-octyl-ascorbic acid reduced the complications of acne vulgaris [52]. On the other hand, in a randomized controlled trial, a cream containing hydroquinone, buffered glycolic acid, vitamins C and E, and sunscreen was safe and effective in melasma treatment [50]. Recently, a serum containing vitamin C, tocopheryl acetate and raspberry leaf cell culture extract had anti-aging and brightening effects on the skin, with significant improvement of skin color, elasticity, and radiance. The smoothness, scaliness, and wrinkles were also improved by topical use of the product once a day, during eight weeks [51].

2.2 Nanotechnology-based formulations

Bioactives molecules and lipophilic vitamins release on or into the skin by topical products comprise a challenging task owing to the characteristics of the stratum corneum barrier. Thereby, the drug accumulates on the skin surface. Besides, vitamin E low stability by its direct exposure to UV radiation can limit conventional formulations effectiveness [58]. Therefore, when it comes to topical administration, nanostructured drug vehicles have shown advantages over conventional delivery systems. The most investigated nanostructured carriers for vitamin E comprise liposomes, nanoemulsions, polymer nanoparticles and lipid-based nanoparticles [54].

Liposomes are self-assembled vesicles composed by one or more hydrophobic bilayers constituted by amphiphilic phospholipids which originate an aqueous core domain. Phospholipids contain phosphorus in their composition [68]. Diversely, nanoemulsions are thermodynamically unstable surfactant-stabilized systems composed of nano-sized micelles bearing an oily nucleus [69]. Polymer nanoparticles, whether nanocapsules or nanospheres, are colloidal artificially prepared spherical carriers surrounded by a polymer membrane. Nanocapsules contain an oily core and nanospheres contain a polymeric matrix [70]. Besides, chitosan obtained from shrimp and crab shells [71] is employed to form polymeric nanoparticles. In these nanoparticles, there is a matrix formed by chitosan and tripolyphosphate. The latter is used as a crosslinking agent [58]. Elseways, lipid nanoparticles either solid lipid nanoparticles (SLN) or nanostructured lipid carriers (NLC) have a lipophilic bioactive entrapped. SLN are formed by a solid lipid-based core while NLC are formed by a mixture of solid and liquid lipids [72]. Figure 2 shows the general structures of some nanocarriers used to deliver vitamin E into skin.

Figure 2.

Structure of some vitamin E nanocarriers. SLN: Solid lipid nanoparticles. NLC: Nanostructured lipid carriers. TPP: Tripolyphosphate. Created in BioRender.

Concerning liposomes, an optimized composition [73], a proper selection of preparation methods and a suitable particle size range [74] are essential as skin penetration will be affected by these factors. Regarding biological activity, vitamin E-loaded liposomes inhibited lipid peroxidation more effectively than free vitamin E [74]. Lately, tocopherol acetate-loaded transferosomes optimized wound healing process [56]. As transferosomes are elastic liposome-like ultra-deformable vesicles, a higher diffusion across the stratum corneum can be accomplished [75, 76]. Topical administration of vitamin E-loaded liposomes are also interesting to enable a high drug penetration and transdermal release into skin tumors [68].

Lipid nanoparticles ability to increase sunscreens efficacy was previously shown [53, 55]. Tocopherol acetate-loaded SLN increased sunscreen UV-blocking effect [53]. Moreover, alpha-tocopherol and sunscreens loaded in NLC and SLN increased vitamin E photostability. Additionally, nanoencapsulated vitamin E promoted a better photoprotection than nanoparticle-based formulation without Vitamin E [55]. Besides, tocopheryl acetate and idebenone loaded in NLC provided a skin hydration increase because lipids have occlusive properties. Vitamin E loaded in NLC reduced skin pigmentation which was attributed to the photoprotective effect of Vitamin E [43].

An innovative nanocomposite dressing for burn wound healing containing vitamin E- loaded polymer nanoparticles allowed a vitamin controlled release [57]. In another report, α-tocopherol loaded to nanospheres was crosslinked to cellulose fiber to obtain a novel cosmetic fabric with potential application to atopic dermatitis patients [58]. As to nanoemulsions, tocopherol-loaded nanoemulsions increased skin delivery in vitro and they protected vitamin E from UV-triggered degradation [54]. More recently, α-tocopherol and γ-tocotrienol were loaded in nanoemulsions to treat dermatitis as an attempt to avoid the use of steroid anti-inflammatory drugs. This nanotechnological formulation could be in the future an alternative to dermatitis patients [59].

Lastly, clinical trials are essential to complement in vitro assays. According to human experiments, different nanosystems could be employed to ensure a more immediate or a more prolonged skin hydration [16]. Beyond skin moisturization, lipid nanoparticles improved human skin elasticity and firmness [9]. Importantly, a protocol clinical trial proposes the use of a formulation containing vitamin E-loaded NLC to reduce radiodermatitis in breast cancer patients. Since radiodermatitis is a recurrent radiotherapy side effect, the use of this topical formulation could improve cancer treatment as there would be lower patients quitting radiotherapy treatment [77].

Advertisement

3. Conclusion

Reactive oxygen species are implicated in systemic and skin diseases pathogenesis. Hence, topical use as well as oral intake of antioxidants should be encouraged to reduce stress oxidative effects. Vitamin E isomers and derivatives are widely known for their antioxidant activity. Tocopherols and tocotrienols isomers are found in vegetable oils. Elseways, vitamin E derivatives are synthetic forms obtained from natural isomers. Endogenously, alpha-tocopherol scavanges reactive oxygen species and owed to this effect, the oral supplementation of vitamin E is beneficial to prevent the appearance and progression of diseases. In relation to cutaneous effects, both oral and topical formulations provide a photoprotection against harmful ultraviolet radiation. Moreover, despite tocotrienols potential application in melanoma treatment, their skin effects are not fully understood.

Majority of skin care formulations contain alpha-tocopherol isoform or tocopherol acetate derivative whose effects are mainly due to their scavenging ROS ability. Therefore, the reduction of skin aging, melasma and cancer prevention can be achieved by different vitamin E pathways on the skin. As conventional forms and nanotechnology-based systems bearing vitamin E are useful in skin diseases treatment, their use is essential to skin health promotion and maintenance. Nevertheless, its therapeutic effectiveness is limited. Vitamin E loaded in nanostructured delivery systems can significantly increase antioxidant-based therapy effectiveness. In the future, there will be a need for well-designed controlled trials to support the benefits of nanotechnology-based products containing this vitamin.

References

  1. 1. Di Vincenzo A, Tana C, El Hadi H, Pagano C, Vettor R, Rossato M. Antioxidant, Anti-Inflammatory, and Metabolic Properties of Tocopherols and Tocotrienols: Clinical Implications for Vitamin E Supplementation in Diabetic Kidney Disease. International Journal of Molecular Sciences. 2019;20:5101-5113. DOI: 10.3390/ijms20205101
  2. 2. Singh A, Kukreti R, Saso L, Kukreti S. Oxidative stress: A key modulator in neurodegenerative diseases. Molecules. 2019;24:1583. DOI: 10.3390/molecules24081583
  3. 3. Chow CK. Vitamin E and oxidative stress. Free Radical Biology and Medicine. 1991;11:215-232. DOI: 10.1016/0891-5849(91)90174-2
  4. 4. McClung J. Vitamin E. In: Combs GF, McClung JP, editors. The Vitamins. 5th ed. London; San Diego: Elsevier; 2017. p. 207-242. DOI: 10.1016/B978-0-12-802965-7.00008-3
  5. 5. Chatziralli IP, Theodossiadis G, Dimitriadis P, Charalambidis M, Agorastos A, Migkos Z, et al. The Effect of Vitamin E on Oxidative Stress Indicated by Serum Malondialdehyde in Insulin-dependent Type 2 Diabetes Mellitus Patients with Retinopathy. The Open Ophthalmology Journal. 2017;11:51-58. DOI: 10.2174/1874364101711010051
  6. 6. Tan S, Chiew Y, Ahmad B, Kadir K. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial. Nutrients. 2018;10:1315-1329. DOI: 10.3390/nu10091315
  7. 7. Szymańska R, Nowicka B, Kruk J. Vitamin E - Occurrence, Biosynthesis by Plants and Functions in Human Nutrition. Mini-Reviews in Medicinal Chemistry. 2016;17:1039-1052. DOI: 10.2174/1389557516666160725094819
  8. 8. Zingg J-M. Molecular and Cellular Activities of Vitamin E Analogues. Mini-Reviews in Medicinal Chemistry. 2007;7:545-560. DOI: 10.2174/138955707780619608
  9. 9. Ijaz M, Akhtar N. Fatty acids based α-Tocopherol loaded nanostructured lipid carrier gel: In vitro and in vivo evaluation for moisturizing and anti-aging effects. Journal of Cosmetic Dermatology. 2020;19:3067-3076. DOI: 10.1111/jocd.13346
  10. 10. Lin JY, Selim MA, Shea CR, Grichnik JM, Omar MM, Monteiro-Riviere NA, et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. Journal of the American Academy of Dermatology. 2003;48:866-874. DOI: 10.1067/mjd.2003.425
  11. 11. Montenegro L, Rapisarda L, Ministeri C, Puglisi G. Effects of lipids and emulsifiers on the physicochemical and sensory properties of cosmetic emulsions containing vitamin E. Cosmetics. 2015;2:35-47. DOI: 10.3390/cosmetics2010035
  12. 12. Gonçalves GMS, Srebernich SM, Souza JA de M. Stability and sensory assessment of emulsions containing propolis extract and/or tocopheryl acetate. Brazilian Journal of Pharmaceutical Sciences. 2011;47:585-592. DOI: 10.1590/S1984-82502011000300016
  13. 13. Moddaresi M, Brown MB, Tamburic S, Jones SA. Tocopheryl acetate disposition in porcine and human skin when administered using lipid nanocarriers. Journal of Pharmacy and Pharmacology. 2010;62:762-769. DOI: 10.1211/jpp.62.06.0013
  14. 14. Stahl W, Heinrich U, Jungmann H, Sies H, Tronnier H. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. American Journal of Clinical Nutrition. 2000;71:795-798. DOI: 10.1093/ajcn/71.3.795
  15. 15. Granger C, Aladren S, Delgado J, Garre A, Trullas C, Gilaberte Y. Prospective Evaluation of the Efficacy of a Food Supplement in Increasing Photoprotection and Improving Selective Markers Related to Skin Photo-Ageing. Dermatology and Therapy. Springer Healthcare; 2020;10:163-178. DOI: 10.1007/s13555-019-00345-y
  16. 16. Vaz S, Silva R, Amaral MH, Martins E, Sousa Lobo JM, Silva AC. Evaluation of the biocompatibility and skin hydration potential of vitamin E-loaded lipid nanosystems formulations: In vitro and human in vivo studies. Colloids and Surfaces B: Biointerfaces. 2019;179:242-249. DOI: 10.1016/j.colsurfb.2019.03.036
  17. 17. Silva S, Ferreira M, Oliveira AS, Magalhães C, Sousa ME, Pinto M, et al. Evolution of the use of antioxidants in anti-ageing cosmetics. International Journal of Cosmetic Science. 2019;41:378-386. DOI: 10.1111/ics.12551
  18. 18. Fiume MZ. Final Report on the Safety Assessment of Tocopherol, Tocopheryl Acetate, Tocopheryl Linoleate, Tocopheryl Linoleate/Oleate, Tocopheryl Nicotinate, Tocopheryl Succinate, Dioleyl Tocopheryl Methylsilanol, Potassium Ascorbyl Tocopheryl Phosphate, and Tocophe. International Journal of Toxicology. 2002;21:51-116. DOI: 10.1080/10915810290169819
  19. 19. Ferrara F, Woodby B, Pecorelli A, Schiavone ML, Pambianchi E, Messano N, et al. Additive effect of combined pollutants to UV induced skin OxInflammation damage. Evaluating the protective topical application of a cosmeceutical mixture formulation. Redox Biology. 2020;34:101481. DOI: 10.1016/j.redox.2020.101481
  20. 20. Lintner K, Gerstein F, Solish N. A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging as evidenced by Primos® analysis and frequently repeated auto-perception. Journal of Cosmetic Dermatology. 2020;19:3262-3269. DOI: 10.1111/jocd.13770
  21. 21. Okebukola PO, Kansra S, Barrett J. Vitamin E supplementation in people with cystic fibrosis. Cochrane Database of Systematic Reviews. 2020;9:CD009422. DOI: 10.1002/14651858.CD009422.pub4
  22. 22. Niki E, Tsuchiya J, Tanimura R, Kamiya Y. Regeneration of Vitamin E From Α-Chromanoxyl Radical By Glutathione and Vitamin C. Chemistry Letters. 1982;11:789-792. DOI: 10.1246/cl.1982.789
  23. 23. Record IR, Dreosti IE, Konstantinopoulos M, Buckley RA. The Influence of Topical and Systemic Vitamin E on Ultraviolet Light-Induced Skin Damage in Hairless Mice. Nutrition and Cancer. 1991;16:219-225. DOI: 10.1080/01635589109514160
  24. 24. Lopez-Torres M, Thiele JJ, Shindo Y, Han D, Packer L. Topical application of α-tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin. British Journal of Dermatology. 1998;138:207-215. DOI: 10.1046/j.1365-2133.1998.02062.x
  25. 25. Weber C, Podda M, Rallis M, Thiele JJ, Traber MG, Packer L. Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation. Free Radical Biology and Medicine. 1997;22:761-769. DOI: 10.1016/S0891-5849(96)00346-2
  26. 26. Saral Y et al., Protective Effects of Topical Alpha-Tocopherol Acetate on UVB Irradiation in Guinea Pigs: Importance of Free Radicals. Physiological Research. 2002;51:285-290
  27. 27. Trevithick JR, Xiong H, Lee S, Shum DT, Sanford SE, Karlik SJ, et al. Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Archives of Biochemistry and Biophysics. 1992;296:575-582. DOI: 10.1016/0003-9861(92)90613-2
  28. 28. Roshchupkin DI, Pistsov MY, Potapenko AY. Inhibition of ultraviolet light-induced erythema by antioxidants. Archives of Dermatological Research. 1979;266:91-94. DOI: 10.1007/BF00412867
  29. 29. Shibata A, Nakagawa K, Kawakami Y, Tsuzuki T, Miyazawa T. Suppression of γ-tocotrienol on UVB induced inflammation in HaCaT keratinocytes and HR-1 hairless mice via inflammatory mediators multiple signaling. Journal of Agricultural and Food Chemistry. 2010;58:7013-7020. DOI: 10.1021/jf100691g
  30. 30. Hochberg M, Kohen R, Enk CD. Role of antioxidants in prevention of pyrimidine dimer formation in UVB irradiated human HaCaT keratinocytes. Biomedicine and Pharmacotherapy. 2006;60:233-237. DOI: 10.1016/j.biopha.2006.04.008
  31. 31. Montagnani Marelli M, Marzagalli M, Moretti RM, Beretta G, Casati L, Comitato R, et al. Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells. Scientific Reports. 2016;6:30502. DOI: 10.1038/srep30502
  32. 32. Fernandes N V., Guntipalli PK, Huanbiao MO. D-δ-tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. Anticancer Research. 2010;30:4937-4944
  33. 33. Michihara A, Morita S, Hirokawa Y, Ago S, Akasaki K, Tsuji H. Delta-Tocotrienol Causes Decrease of Melanin Content in Mouse Melanoma Cells. Journal of Health Science. 2009;55:314-318. DOI: 10.1248/jhs.55.314
  34. 34. Makpol S, Arifin NM, Ismail Z, Hui CK, Anum Y, Yusof M, et al. Modulation of melanin synthesis and its gene expression in skin melanocytes by palm tocotrienol rich fraction. African Journal of Biochemistry Research. 2009;3:385-392
  35. 35. Makpol S, Jam FA, Rahim NA, Khor SC, Ismail Z, Yusof YAM, et al. Comparable down-regulation of TYR, TYRP1 and TYRP2 genes and inhibition of melanogenesis by tyrostat, tocotrienol-rich fraction and tocopherol in human skin melanocytes improves skin pigmentation. La Clinica Terapeutica. 2014;165:e39–e45. DOI: 10.7471/CT.2014.1670
  36. 36. Makpol S, Jam FA, Yusof YAM, Ngah WZW. Modulation of collagen synthesis and its gene expression in human skin fibroblasts by tocotrienol-rich fraction. Archives of Medical Science. 2011;7:889-895. DOI: 10.5114/aoms.2011.25567
  37. 37. Makpol S, Jam FA, Khor SC, Ismail Z, Mohd Yusof YA, Wan Ngah WZ. Comparative effects of biodynes, tocotrienol-rich fraction, and tocopherol in enhancing collagen synthesis and inhibiting collagen degradation in stress-induced premature senescence model of human diploid fibroblasts. Oxidative Medicine and Cellular Longevity. 2013;2013:298574. DOI: 10.1155/2013/298574
  38. 38. Bickers DR, Athar M. Oxidative Stress in the Pathogenesis of Skin Disease. The Journal of Investigative Dermatology. 2006;126:2565-2575. DOI: 10.1038/sj.jid.5700340
  39. 39. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. Oxidative Stress and Its Role in Skin Disease. Antioxidants & Redox Signaling. 2002;4:665-673. DOI: 10.1089/15230860260220175
  40. 40. Zhou Q , Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radical Biology & Medicine. 2009;47:891-905. DOI: 10.1016/j.freeradbiomed.2009.06.033
  41. 41. Yap WN. Tocotrienol-rich fraction attenuates UV-induced inflammaging: A bench to bedside study. Journal of Cosmetic Dermatology. 2018;17:555-565. DOI: 10.1111/jocd.12421
  42. 42. Mukul S, Surabhi K, Atul N. Cosmeceuticals for the skin: an overview. Asian Journal of Pharmaceutical and Clinical Research. 2011;4:1-6
  43. 43. Montenegro L, Messina CM, Manuguerra S, Santagati LM, Pasquinucci L, Turnaturi R, et al. In vitro antioxidant activity and in vivo topical efficacy of lipid nanoparticles co-loadingm idebenone and tocopheryl acetate. Applied Sciences. 2019;9:845. DOI: 10.3390/app9050845
  44. 44. Thiele JJ, Hsieh SN, Ekanayake-Mudiyanselage S. Vitamin E: critical review of its current use in cosmetic and clinical dermatology. Dermatologic surgery : official publication for American Society for Dermatologic Surgery. 2005;31:805-813. DOI: 10.1111/j.1524-4725.2005.31724
  45. 45. Keen M, Hassan I. Vitamin E in dermatology. Indian Dermatology Online Journal. 2016;7:311-315DOI: 10.4103/2229-5178.185494
  46. 46. Neophytou CM, Constantinou AI. Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives. BioMed Research International. 2015;2015:584862. DOI: 10.1155/2015/584862
  47. 47. Darr D, Duston S, Faust H, Pinell S. Effectiveness of Antioxidants (Vitamin C and E) With and Without Sunscreen as Topical Photoprotectants. Acta Dermato-Venereologica. 1996;76:264-268. DOI: 10.2340/0001555576264268
  48. 48. Zhai H, Behnam S, Villarama CD, Arens-Corell M, Choi MJ, Maibach HI. Evaluation of the Antioxidant Capacity and Preventive Effects of a Topical Emulsion and Its Vehicle Control on the Skin Response to UV Exposure. Skin Pharmacology and Physiology. 2005;18:288-293. DOI: 10.1159/000088014
  49. 49. Afonso S, Horita K, Sousa e Silva JP, Almeida IF, Amaral MH, Lobão PA, et al. Photodegradation of avobenzone: Stabilization effect of antioxidants. Journal of Photochemistry and Photobiology B: Biology. 2014;140:36-40. DOI: 10.1016/j.jphotobiol.2014.07.004
  50. 50. Guevara IL, Pandya AG. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. International Journal of Dermatology. 2003;42:966-972. DOI: 10.1111/j.1365-4632.2003.02017.x
  51. 51. Rattanawiwatpong P, Wanitphakdeedecha R, Bumrungpert A, Maiprasert M. Anti-aging and brightening effects of a topical treatment containing vitamin C, vitamin E, and raspberry leaf cell culture extract: A split-face, randomized controlled trial. Journal of Cosmetic Dermatology. 2020;19:671-676. DOI: 10.1111/jocd.13305
  52. 52. Kurokawa I, Yoshioka M, Ito S. Split-face comparative clinical trial using glyceryl-octyl-ascorbic acid/ascorbyl 2-phosphate 6-palmitate/DL-α-tocopherol phosphate complex treatment for postinflammatory hyperpigmentation, postinflammatory erythema and atrophic scar in acne vulgaris. The Journal of Dermatology. 2019;46:e347–e348. DOI: 10.1111/1346-8138.14930
  53. 53. Wissing SA, Müller RH. A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. International Journal of Cosmetic Science. 2001;23:233-243. DOI: 10.1046/j.1467-2494.2001.00087.x
  54. 54. Abla MJ, Banga AK. Formulation of tocopherol nanocarriers and in vitro delivery into human skin. International Journal of Cosmetic Science. 2014;36:239-246. DOI: 10.1111/ics.12119
  55. 55. Niculae G, Lacatusu I, Bors A, Stan R. Photostability enhancement by encapsulation of α-tocopherol into lipid-based nanoparticles loaded with a UV filter. Comptes Rendus Chimie. 2014;17:1028-1033. DOI: 10.1016/j.crci.2013.12.007
  56. 56. Caddeo C, Manca ML, Peris JE, Usach I, Diez-Sales O, Matos M, et al. Tocopherol-loaded transfersomes: In vitro antioxidant activity and efficacy in skin regeneration. International Journal of Pharmaceutics. 2018;551:31-41. DOI: 10.1016/j.ijpharm.2018.09.009
  57. 57. Pereira GG, Detoni CB, Balducci AG, Rondelli V, Colombo P, Guterres SS, et al. Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds. European Journal of Pharmaceutical Sciences. 2016;83:203-211. DOI: 10.1016/j.ejps.2016.01.002
  58. 58. Raza ZA, Abid S, Azam A, Rehman A. Synthesis of alpha-tocopherol encapsulated chitosan nano-assemblies and their impregnation on cellulosic fabric for potential antibacterial and antioxidant cosmetotextiles. Cellulose. 2020;27:1717-1731. DOI: 10.1007/s10570-019-02862-7
  59. 59. Harun MS, Wong TW, Fong CW. Advancing skin delivery of α-tocopherol and γ-tocotrienol for dermatitis treatment via nanotechnology and microwave technology. International Journal of Pharmaceutics. 2021;593:120099. DOI: 10.1016/j.ijpharm.2020.120099
  60. 60. Yap SP, Yuen KH, Lim AB. Influence of route of administration on the absorption and disposition of α,- γ- and δ-tocotrienols in rats. Journal of Pharmacy and Pharmacology. 2003;55:53-58. DOI: 10.1111/j.2042-7158.2003.tb02433.x
  61. 61. Lohani A, Verma A, Joshi H, Yadav N, Karki N. Nanotechnology-Based Cosmeceuticals. ISRN Dermatology. 2014;2014:843687. DOI: 10.1155/2014/843687
  62. 62. Zoabi A, Touitou E, Margulis K. Recent advances in nanomaterials for dermal and transdermal applications. Colloids and Interfaces. 2021;5:18. DOI: 10.3390/colloids5010018
  63. 63. Thiele JJ, Ekanayake-Mudiyanselage S. Vitamin E in human skin: Organ-specific physiology and considerations for its use in dermatology. Molecular Aspects of Medicine. 2007;28:646-667. DOI: 10.1016/j.mam.2007.06.001
  64. 64. Rangarajan M, Zatz JL. Effect of formulation on the topical delivery of o-tocopherol. Journal of cosmetic science. 2003;54:161-174
  65. 65. Masaki H. Role of antioxidants in the skin: Anti-aging effects. Journal of Dermatological Science. 2010;58:85-90. DOI: 10.1016/j.jdermsci.2010.03.003
  66. 66. Gensler HL, Aickin M, Peng Y, Xu M. Importance of the form of topical vitamin E for prevention of photocarcinogenesis. Nutrition and Cancer. 1996;26:183-191. DOI: 10.1080/01635589609514474
  67. 67. Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC. Skin anti-aging strategies. Dermato-Endocrinology. 2012;4:308-319. DOI: 10.4161/derm.22804
  68. 68. Koudelka S, Turanek Knotigova P, Masek J, Prochazka L, Lukac R, Miller AD, et al. Liposomal delivery systems for anti-cancer analogues of vitamin E. Journal of Controlled Release. 2015;207:59-69. DOI: 10.1016/j.jconrel.2015.04.003
  69. 69. Barradas TN, de Holanda e Silva KG. Nanoemulsions of essential oils to improve solubility, stability and permeability: a review. Environmental Chemistry Letters. 2021;19:1153-1171. DOI: 10.1007/s10311-020-01142-2
  70. 70. Zielińska A, Carreiró F, Oliveira AM, Neves A, Pires B, Venkatesh DN, et al. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules. 2020;25:3731. DOI: 10.3390/molecules25163731
  71. 71. Nwe N, Furuike T, Tamura H. Isolation and Characterization of Chitin and Chitosan from Marine Origin. In: Kim S-K, editor. Advances in Food and Nutrition Research. 1st ed. London; San Diego;Oxford: Elsevier; 2014. p. 1-15. DOI: 10.1016/B978-0-12-800269-8.00001-4
  72. 72. Kakadia P, Conway B. Lipid Nanoparticles for Dermal Drug Delivery. Current Pharmaceutical Design. 2015;21:2823-2829. DOI: 10.2174/1381612821666150428143730
  73. 73. Padamwar M, Pokharkar V. Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability. International Journal of Pharmaceutics. 2006;320:37-44. DOI: 10.1016/j.ijpharm.2006.04.001
  74. 74. Natsuki R, Morita Y, Osawa S, Takeda Y. Effects of Liposome Size on Penetration of dl-Tocopherol Acetate into Skin. Biological & Pharmaceutical Bulletin. 1996;19:758-761. DOI: 10.1248/bpb.19.758
  75. 75. Rajan R, Vasudevan D, Biju Mukund V, Jose S. Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation. Journal of Advanced Pharmaceutical Technology & Research. 2011;2:138-143. DOI: 10.4103/2231-4040.85524
  76. 76. Fernández-García R, Lalatsa A, Statts L, Bolás-Fernández F, Ballesteros MP, Serrano DR. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. International Journal of Pharmaceutics. 2020;573:118817. DOI: 10.1016/j.ijpharm.2019.118817
  77. 77. Schmidt FMQ , Serna González C V., Mattar RC, Lopes LB, dos Santos MF, de Gouveia Santos VLC. Topical cream containing nanoparticles with Vitamin E to prevent radiodermatitis in women with breast cancer: A clinical trial protocol. Journal of Wound Care. 2021;30:S44–S50. DOI: 10.12968/jowc.2021.30.sup6.s44

Written By

Júlia Scherer Santos, Guilherme Diniz Tavares and Thaís Nogueira Barradas

Submitted: 13 July 2021 Reviewed: 15 July 2021 Published: 17 August 2021